Persistence and selection of an expanded B-cell clone in the setting of rituximab therapy for Sjögren’s syndrome

INTRODUCTION: Subjects with primary Sjögren’s syndrome (SjS) have an increased risk of developing B-cell lymphoma and may harbor monoclonal B-cell expansions in the peripheral blood. Expanded B-cell clones could be pathogenic, and their persistence could exacerbate disease or predispose toward the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Hershberg, Uri, Meng, Wenzhao, Zhang, Bochao, Haff, Nancy, St Clair, E William, Cohen, Philip L, McNair, Patrice D, Li, Ling, Levesque, Marc C, Luning Prak, Eline T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978607/
https://www.ncbi.nlm.nih.gov/pubmed/24517398
http://dx.doi.org/10.1186/ar4481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978607/
https://www.ncbi.nlm.nih.gov/pubmed/24517398
http://dx.doi.org/10.1186/ar4481

Ejemplares similares